MedPath

Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure

Not yet recruiting
Conditions
End Stage Renal Failure
Secondary Hyperparathyroidism
Interventions
Other: Quality of life progression after parathyroidectomy
Registration Number
NCT06378931
Lead Sponsor
Chunling Jiang
Brief Summary

The purpose of this study is to characterize the quality of life change in patients undergoing parathyroidectomy with secondary hyperparathyroidism due to end-stage renal failure.

Detailed Description

Study participants will be asked questions about age, gender, education level, clinical symptoms, intensities of depression and anxiety, etc, and they will also be questioned regarding the prior quality of life score, as measured by the health-related quality of life 36-item Short-Form (SF-36) survey before surgery. Then, study participants will be contacted at one, three, six months, and 1 year after surgery, and asked questions about their SF-36 score, depression, and anxiety intensity.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age: ≥18 years old;
  • Patients scheduled for parathyroidectomy with secondary hyperparathyroidism due to end-stage renal failure
Exclusion Criteria

• Patients refuse to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Quality of life change in patients Undergoing Parathyroidectomy with end-stage renal failureQuality of life progression after parathyroidectomyQuality of Life Progression in Patients Undergoing Parathyroidectomy With Secondary Hyperparathyroidism Due to End-stage Renal Failure
Primary Outcome Measures
NameTimeMethod
Measure quality of life scores change with respect to timeup to 1 year

Quality of life will be assessed by the 36-Item short form health survey scale, Subjects complete one response from a range of options for each of the 36 questions. A combination of item response is then aggregated to calculate a score for each of the eight dimensions listed. The scores for each dimension range from 0 to 100, with higher scores indicating better health status

Secondary Outcome Measures
NameTimeMethod
Length of hospital staythrough study completion, an average of 1 week

Determined by the number of days from admittance to discharge

Measure bone pain scores change with respect to timeup to 1 year

The bone pain is evaluated using numerical rating scale (NRS). NRS scores range from 0 to 10 points, with 0 points representing no pain, 1-3 points representing mild pain, 4-6 points representing moderate pain, 7-9 points representing severe pain and 10 points representing the strongest pain.

Measure anxiety and depression score change with respect to timeup to 1 year

The anxiety and depression were evaluated using Hospital anxiety and depression Scale (HADS). The HADS consists of 14 questions, with 7 items each for the anxiety and depression subscales. The score for each item ranges from 0 to 3 points, and scores are summed to yield a separate score for anxiety (HADS-A) and depression (HADS-D).

© Copyright 2025. All Rights Reserved by MedPath